News

The company supplied approximately five million doses of Morupar vaccine in 2005, providing most of its production to a limited number of developing countries, largely via the United

The open label dose finding study, dubbed XACT, involves dosing of AMD070 twice daily for 10 consecutive days. There are up to 4 cohorts with a total of

Upon closing of the transaction, Hana will pay Inex $11.5 million in an upfront payment, consisting of cash and Hana shares. Inex will receive an additional $30.5 million

The amended protocol now includes a higher dose and increases the number of patients targeted for enrollment from 40 to 120. Under the amended protocol, the study is

Pradefovir is a pro-drug of adefovir that was licensed from Metabasis Therapeutics. Pradefovir uses Metabasis’ HepDirect technology which enables higher concentrations of the drug in the liver, the

The company’s siRNAs are specifically designed to target conserved regions of the influenza viral genome which could enable a siRNA therapeutic to be effective against both current and

Scientists from the University of California and Stanford University looked at the use of the statin Lipitor in combination with Teva Pharmaceutical’s Copaxone, a drug already approved for

Rituxan is normally used to treat lymphoma, rheumatoid arthritis and other immune disorders. “If the drug is effective, it could help prevent some of the long-term complications that

Oxycyte is Synthetic Blood’s proprietary perfluorocarbon (PFC) therapeutic oxygen carrier and blood substitute. The formulation will be investigated in eight patients with severe traumatic brain injury. “We are